Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-488,970
Closed -$172M 98
2026
Q1
$172M Sell
488,970
-800
-0.2% -$285K 9.25% 4
2025
Q4
$160M Sell
489,770
-700
-0.1% -$222K 8.09% 4
2025
Q3
$138M Buy
490,470
+4,823
+1% +$1.4M 11.79% 3
2025
Q2
$136M Buy
+485,647
New +$138M 9.72% 4

Other funds holding AMGN

Mizuho Markets Cayman's AMGN Position: Q2 2026 in Review

Mizuho Markets Cayman sold out of Amgen (AMGN) in Q2 2026, closing a stake of 488,970 shares — an estimated $172M sold.

Mizuho Markets Cayman first reported a position in AMGN in Q2 2025 and held it in 4 quarters. The position peaked at $172M in Q1 2026. 1,173 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mizuho Markets Cayman reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Mizuho Markets Cayman sold 488,970 Amgen shares in Q2 2026, an estimated $172M.
  • Mizuho Markets Cayman first reported a position in Amgen in Q2 2025 and held it in 4 quarters.
  • Mizuho Markets Cayman's Amgen position peaked at $172M in Q1 2026.
  • 1,173 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mizuho Markets Cayman's 13F filing for Q2 2026, filed 24 Jul 2026.